130 related articles for article (PubMed ID: 23964733)
1. Commentary: non-haemodynamic effects of beta-blockers in cirrhosis - more than meets the eye? Authors' reply.
Bajaj JS; Ratliff S; Lapane K
Aliment Pharmacol Ther; 2013 Sep; 38(6):653. PubMed ID: 23964733
[No Abstract] [Full Text] [Related]
2. Commentary: non-haemodynamic effects of beta-blockers in cirrhosis--more than meets the eye?
Sharma S; Feld JJ
Aliment Pharmacol Ther; 2013 Sep; 38(6):652. PubMed ID: 23964732
[No Abstract] [Full Text] [Related]
3. Bacterial translocation and nonselective β-blockers in portal hypertension: where we are, what we still need.
La Mura V; Colombo M
Gastroenterology; 2014 Jul; 147(1):247-9. PubMed ID: 24866430
[No Abstract] [Full Text] [Related]
4. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
Reiberger T; Ferlitsch A; Payer BA; Mandorfer M; Heinisch BB; Hayden H; Lammert F; Trauner M; Peck-Radosavljevic M; Vogelsang H;
J Hepatol; 2013 May; 58(5):911-21. PubMed ID: 23262249
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation.
Montes-de-Oca M; Blanco MJ; Marquez M; Soto MJ; Fernandez-Gutiérrez C; Rodriguez-Ramos C; Giron-Gonzalez JA
Liver Int; 2011 Jul; 31(6):850-8. PubMed ID: 21645216
[TBL] [Abstract][Full Text] [Related]
6. Letter: non-selective beta-blockers in cirrhosis-effect beyond portal hypertension. Authors' reply.
Dunne P; Young D; Chuah CS; Hayes P; Tripathi D; Leithead J; Smith L; Gaya D; Forrest E; Stanley AJ
Aliment Pharmacol Ther; 2022 Jul; 56(1):186-187. PubMed ID: 35689317
[No Abstract] [Full Text] [Related]
7. Oral propranolol decreases intestinal permeability in patients with cirrhosis: another protective mechanism against bleeding?
Senzolo M; Fries W; Buda A; Pizzuti D; Nadal E; Sturniolo GC; Burroughs AK; D'Incà R
Am J Gastroenterol; 2009 Dec; 104(12):3115-6. PubMed ID: 19956145
[No Abstract] [Full Text] [Related]
8. Beta-adrenergic blockers in cirrhosis.
Lancet; 1985 Jun; 1(8442):1372-3. PubMed ID: 2861319
[No Abstract] [Full Text] [Related]
9. Beta-blockers in cirrhosis: thank you for your attention.
Ge PS; Runyon BA
J Hepatol; 2014 Aug; 61(2):451-2. PubMed ID: 24792969
[No Abstract] [Full Text] [Related]
10. Beta-blockers in cirrhosis: therapeutic window or an aspirin for all?
Ferrarese A; Tsochatzis E; Burroughs AK; Senzolo M
J Hepatol; 2014 Aug; 61(2):449-50. PubMed ID: 24768827
[No Abstract] [Full Text] [Related]
11. Continued controversy over the safety of beta-blockers in decompensated cirrhosis.
Albillos A; Martínez J; Téllez L
Hepatology; 2016 May; 63(5):1726-9. PubMed ID: 26474289
[No Abstract] [Full Text] [Related]
12. Beta blockers in cirrhosis: The window re-opens.
Garcia-Tsao G
J Hepatol; 2016 Mar; 64(3):532-4. PubMed ID: 26724557
[No Abstract] [Full Text] [Related]
13. An apology for beta blockers.
Thalheimer U; Bosch J; Burroughs AK
J Hepatol; 2014 Aug; 61(2):450-1. PubMed ID: 24768757
[No Abstract] [Full Text] [Related]
14. The changing role of beta-blocker therapy in patients with cirrhosis.
Ge PS; Runyon BA
J Hepatol; 2014 Mar; 60(3):643-53. PubMed ID: 24076364
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections.
Galbois A; Das V; Thabut D; Maury E; Ait-Oufella H; Housset C; Guidet B
Hepatology; 2011 Apr; 53(4):1412-3. PubMed ID: 21480358
[No Abstract] [Full Text] [Related]
16. The potential of lipopolysaccharide-binding protein to predict the severity and prognosis of cirrhotic patients with severe sepsis.
Yang YY
J Chin Med Assoc; 2014 Feb; 77(2):57-8. PubMed ID: 24216237
[No Abstract] [Full Text] [Related]
17. Effects of beta-blockers on survival for patients with cirrhosis and refractory ascites.
Lo GH
Hepatology; 2011 Mar; 53(3):1068-9. PubMed ID: 21374686
[No Abstract] [Full Text] [Related]
18. Letter: Confounders and outcomes in studies of beta-blockers in liver disease-role of PPIs? Authors' reply.
Sasso R; Rockey DC
Aliment Pharmacol Ther; 2021 Jul; 54(1):91. PubMed ID: 34109670
[No Abstract] [Full Text] [Related]
19. Increased intestinal permeability in deceased brain dead rats.
Koudstaal LG; Ottens PJ; Uges DR; Ploeg RJ; van Goor H; Leuvenink HG
Transplantation; 2009 Aug; 88(3):444-6. PubMed ID: 19667953
[No Abstract] [Full Text] [Related]
20. Prophylaxis with beta blockers as a performance measure of quality health care in cirrhosis.
Talwalkar JA
Gastroenterology; 2006 Mar; 130(3):1005-7. PubMed ID: 16530542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
